Beta-aminopropionitrile as a radiation reaction preventive agent

Area of Science:

• Biomedical research
• Pharmacology
• Radiology

Background:

• Radiation therapy can cause lung damage, leading to fibrosis.
• Collagen maturation is a key process in fibrotic tissue development.

Purpose of the Study:

• To evaluate beta-aminopropionitrile (BAPN) as a radiation reaction preventive agent (RRPA).
• To assess BAPN's efficacy in preventing radiation-induced lung fibrosis in a rodent model.

Main Methods:

• Rats and mice were exposed to pulmonary irradiation.
• Beta-aminopropionitrile (BAPN) was administered post-irradiation.
• Collagen content was measured using hydroxyproline analysis.
• Mouse lung LD50/160 was determined to assess toxicity.

Main Results:

• BAPN significantly inhibited the increase in lung collagen content post-irradiation.
• The antifibrotic effect of BAPN was sustained for up to 10 weeks during continuous administration.
• Discontinuation of BAPN led to the loss of its protective effect.
• The tested doses of BAPN did not increase the mouse lung LD50/160, indicating a lack of significant toxicity.

Conclusions:

• Beta-aminopropionitrile (BAPN) demonstrates potential as a radiation reaction preventive agent against lung fibrosis.
• Sustained administration is necessary to maintain the antifibrotic effects of BAPN.
• Further investigation into other potential RRPAs like D-penicillamine and beclomethasone dipropionate is warranted.